Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaprolac K40 for moderate to severe seborrhoeic dermatitis of the scalp
2006-005242-36Phase 2Completed
- Sponsor
- Moberg Pharma AB
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in seborrheic dermatitis (SD) comparing Kaprolac K40 with Placebo (2 arms). Started Oct 2006; status: completed.
02
Drugs
Kaprolac K40
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on 2006-005242-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005242-36.